Aaron Iding

University of Maastricht

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

kathleen freson

Prof

Katholieke Universiteit Leuven

BELGIUM

View details

Johan Heemskerk

Emeritus Prof. of Cell Biochemistry of Thrombosis and Haemostasis

University of Maastricht

NETHERLANDS

View details

Hugo ten Cate

Professor

NETHERLANDS

View details

Ruth Anne Laura Willems

Maastricht University Medical Centre

NETHERLANDS

View details

Paul Armstrong

Lecturer in Pharmacology

Queen Mary University of London

UNITED KINGDOM

View details

Sofia Ramström

Ass. prof

Örebro university

SWEDEN

View details

Constance Baaten

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aaron Iding

Research Interests

Explore related searches

Contact this professor

Articles (16)

Toward standardization and a concerted vision for platelet proteomics research: communication from the SSC of the ISTH.

Untangling profiles of postthrombotic syndrome using unsupervised machine learning

Fibrinogen levels and clot properties identify patients who benefit from catheter-directed thrombolysis after DVT

Interdisciplinarity within thrombosis and hemostasis

Patency and reflux in relation to post-thrombotic syndrome

Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study

Blood coagulation and beyond: Position paper from the Fourth Maastricht Consensus Conference on Thrombosis.

Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study

Determining ‘thrombogenicity’ in patients with coronary artery disease: what’s next?

Coping with setbacks as early career professionals

Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence

Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.

Challenges facing early career women in thrombosis and hemostasis—meeting the needs of the next generation

How to optimize the prevention of post‑thrombotic syndrome: recent advances.

Impact of the COVID‐19 pandemic on education and clinical training

Leukocyte gene expression in post-thrombotic syndrome.

Collaborators (7)

kathleen freson

Johan Heemskerk

Hugo ten Cate

Ruth Anne Laura Willems

Paul Armstrong

Sofia Ramström

Constance Baaten

Make your next move.